Rome R&D Tax Credit Benefits for Your Business

R&D Tax Credits for Rome, Georgia Businesses

Rome, Georgia, is home to a diverse range of industries, including manufacturing, healthcare, education, technology, and logistics. Some of the top companies in the area include Georgia Power, Berry College, Floyd Medical Center, Pirelli Tire, and Mount Vernon Mills. These industries and businesses can benefit significantly from the Research and Development (R&D) Tax Credit, which incentivizes innovation by reducing tax liabilities for companies investing in qualifying R&D activities.The R&D Tax Credit not only helps companies save on taxes but also fosters growth and innovation, driving long-term economic benefits for the region.

Find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 400 West Peachtree Street NW, Atlanta, Georgia is less than 70 miles away from Rome and provides R&D tax credit consulting and advisory services to Rome and the surrounding areas such as: Cartersville, Calhoun, Dallas, Cedartown and Acworth.

If you have any questions or need further assistance, please call or email our local Georgia Partner on (404) 448-1354.
Feel free to book a quick teleconference with one of our Georgia R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Rome, Georgia Patent of the Year – 2024/2025

GLOBAL HEALTH SOLUTIONS LLC has been awarded the 2024/2025 Patent of the Year for advancing topical drug delivery. Their invention, detailed in U.S. Patent No. 12083221, titled ‘Petrolatum-based delivery systems and for active ingredients’, utilizes petrolatum-based emulsions to stabilize and deliver active pharmaceutical ingredients.

This innovation addresses a longstanding challenge in topical medicine: maintaining the stability and effectiveness of active compounds over time. By suspending these ingredients in a petrolatum matrix, the formulation enhances shelf life and ensures consistent therapeutic delivery. This approach is particularly beneficial for treatments targeting skin infections and fungal conditions.

The patent outlines methods for creating stable emulsions without relying on traditional emulsifiers. This not only simplifies the formulation process but also reduces potential irritants, making the product more suitable for sensitive skin.

The versatility of this delivery system allows for its application across various medical treatments, potentially improving patient outcomes and adherence.
Inventor Bradley Burnam has a history of developing petrolatum-based therapeutic solutions. This latest patent builds upon his previous work, offering a more refined and effective delivery mechanism. The technology promises to streamline the production of topical medications, potentially lowering costs and expanding access to effective treatments.

As the medical community continues to seek efficient and patient-friendly drug delivery methods, this petrolatum-based system represents a significant step forward. Its adoption could lead to more reliable and accessible treatments for a range of skin-related health issues.